ASCO publishes a suite of peer-reviewed journals with content focused on

  • clinical oncology research;
  • issues and insights affecting oncology practice;
  • cancer care, research and care delivery issues unique to countries and settings with limited healthcare resources;
  • biomedical informatics methods and processes applied to cancer-related data, information, and images; and
  • the science and practice of precision oncology.

ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author.

ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles.

Publishing October 15, 2020, 4:00 pm ET: 

Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy (Editorial)
Paul Bröckelmann, et al.
Request this article

Defining the Optimal Treatment of First Relapse of Pediatric Relapsed Anaplastic Large-Cell Lymphoma: Clinical Trial Challenges for Rare Diagnoses (Original Report)
Maureen O'Brien, et al.
Request this article

How Is Geriatric Assessment Used in Clinical Practice for Older Adults With Cancer? A Survey of Cancer Providers by the American Society of Clinical Oncology (ASCO Special Article)
William Dale, et al.
Request this article

Publishing October 14, 2020, 4:00 pm ET: 

Evolving Evidence in Support of Sentinel Lymph Node Biopsy for Early-Stage Oral Cavity Cancer (Original Report)
Robert Ferris, et al.
Request this article

Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial (Original Report)
Tim Eisen, et al.
Request this article

Road Map to Safe and Well-Designed De-escalation Trials of Systemic Adjuvant Therapy for Solid Tumors (Original Report)
Florentine Hilbers, et al.
Request this article

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia (Original Report)
Tim Somervaille, et al.
Request this article

Equivalence Randomized Trial to Compare Treatment on the Basis of Sentinel Node Biopsy Versus Neck Node Dissection in Operable T1-T2N0 Oral and Oropharyngeal Cancer (Original Report)
Renaud Garrel, et al.
Request this article

ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer (Original Report)
Maria Gebre-Medhin, et al.
Request this article

Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial (Original Report)
Xin Huang, et al.
Request this article

Developing a Community for Patients With Cancer Through Longer-Term Art Therapy (Original Contribution)
Sam Brondfield, et al.
Request this article

Publishing October 13, 2020, 4:00 pm ET: 

Four-Factor Score for Outcome of Ibrutinib Treatment in Chronic Lymphocytic Leukemia: Prognostic Model for Risk Group Definition  (Editorial)
Stephen Stilgenbauer, et al.
Request this article

Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH) (Original Report)
Keith Flaherty, et al.
Request this article

Publishing October 8, 2020, 4:00 pm ET: 

Continuum of Care for Hodgkin Lymphoma: Impact of Modern Therapy on Postacute Morbidity and Mortality (Editorial)
Andrew Evens, et al.
Request this article

Accuracy of SIE/SIES/GITMO Consensus Criteria for Unfitness to Predict Early Mortality After Intensive Chemotherapy in Adults With AML or Other High-Grade Myeloid Neoplasm (Original Report)
Roland Walter, et al.
Request this article

Rate of Whole-Breast Hypofractionated Radiation Therapy Before Versus After Virtual Tumor Board Implementation (Original Contribution)
Adam Powell, et al.
Request this article

Publishing October 5, 2020, 4:00 pm ET: 

Cardiac Screening for Childhood Cancer Survivors Can Be Improved With Existing Technology (Editorial)
David Hodgsnon, et al.
Request this article

Prospective Cohort Study of Pre- and Postdiagnosis Physical Activity and Endometrial Cancer Survival (Original Report)
Christine Friedenreich, et al.
Request this article

Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic Model  (Original Report)
Inhye Ahn, et al.
Request this article

Exploring the Experiences of Patients in the Oncology Care Model (Original Contribution)
Elizabeth Franklin, et al.
Request this article

Disparities at the Intersection of Race and Ethnicity: Examining Trends and Outcomes in Hispanic Women With Breast Cancer (Original Contribution)
Lola Fayanju, et al.
Request this article

Analysis of the Implementation of Telehealth Visits for Care of Patients With Cancer in Houston During the COVID-19 Pandemic (Original Contribution)
Jorge Darcourt, et al.
Request this article

Publishing October 2, 2020, 4:00 pm ET: 

Barriers to Schooling in Survivorship: The Role of Neuropsychological Assessment (Original Contribution)
Lisa Jacobson, et al.
Request this article

Timing, Costs, and Survival Outcome of Specialty Palliative Care in Medicare Beneficiaries With Metastatic Non--Small-Cell Lung Cancer (Original Contribution)
Jinhai Hong, et al.
Request this article

Personalized Clinical Research: Childhood Cancer Survivor and Parent Preferences for Research Participation (Editorial)
Karim Sadak, et al.
Request this article

Nearly Half of TP53 Germline Variants Predicted To Be Pathogenic in Patients With Osteosarcoma Are De Novo: A Report From the Children's Oncology Group (Original Report)
Logan Spector, et al.
Request this article

Exploiting Rules to Enhance Machine Learning in Extracting Information From Multi-Institutional Prostate Pathology Reports (Original Report)
Amir Tahmasebi, et al.
Request this article

The embargo date and time of a journal article coincide with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year and may affect broader ASCO media privileges as well. Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.